MAGOHB and glioblastoma: Altogether, these results indicate that reduced expression of MAGOH/MAGOHB can create aberrant splicing events in glioblastoma cells, and suggest that high MAGOH/MAGOHB expression in tumours has an important role in preventing such events that are potentially harmful to tumour cells.